Weidong Dai - Fresh2 China President
| FRES Stock | 1.39 0.08 6.11% |
President
Weidong Dai is China President of Fresh2 Group
| Age | 63 |
| Address | 650 5th Ave, New York, NY, United States, 10019-6108 |
| Web | https://fresh2.co |
Fresh2 Management Efficiency
The company has return on total asset (ROA) of (0.6197) % which means that it has lost $0.6197 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.1623) %, meaning that it created substantial loss on money invested by shareholders. Fresh2's management efficiency ratios could be used to measure how well Fresh2 manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Fresh2's Return On Capital Employed is comparatively stable compared to the past year. Return On Equity is likely to gain to 7.04 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (2.22). At this time, Fresh2's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 32.3 M in 2024, whereas Intangible Assets are likely to drop slightly above 1.1 M in 2024.Similar Executives
| Found 8 records | PRESIDENT Age | ||
| Ashok Bhandari | Protagonist Therapeutics | 60 | |
| Stephen Betz | Crinetics Pharmaceuticals | 58 | |
| Suneel Gupta | Protagonist Therapeutics | 66 | |
| Hui Liu | Merus BV | 57 | |
| Robert Wong | Cytokinetics | 56 | |
| Mark Smythe | Protagonist Therapeutics | 59 | |
| Neil MD | Syndax Pharmaceuticals | 60 | |
| Ching Jaw | Cytokinetics | 61 | |
Management Performance
| Return On Equity | -2.16 | ||||
| Return On Asset | -0.62 |
Fresh2 Group Leadership Team
Elected by the shareholders, the Fresh2's board of directors comprises two types of representatives: Fresh2 inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Fresh2. The board's role is to monitor Fresh2's management team and ensure that shareholders' interests are well served. Fresh2's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Fresh2's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sunil Pandit, U Officer | ||
| Xiaoyu Li, Director CFO | ||
| Yidong Hu, Chief Officer | ||
| Weidong Dai, China President | ||
| Haohan Xu, Chairman CEO | ||
| He Yu, CoFounder Scientist |
Fresh2 Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Fresh2 a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.16 | ||||
| Return On Asset | -0.62 | ||||
| Operating Margin | (6.99) % | ||||
| Current Valuation | 3.37 M | ||||
| Shares Outstanding | 2.45 M | ||||
| Shares Owned By Institutions | 0.04 % | ||||
| Number Of Shares Shorted | 11.89 K | ||||
| Price To Book | 0.27 X | ||||
| Price To Sales | 0.20 X | ||||
| Revenue | 12.04 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fresh2 Stock Analysis
When running Fresh2's price analysis, check to measure Fresh2's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresh2 is operating at the current time. Most of Fresh2's value examination focuses on studying past and present price action to predict the probability of Fresh2's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresh2's price. Additionally, you may evaluate how the addition of Fresh2 to your portfolios can decrease your overall portfolio volatility.